NCT01484847View on ClinicalTrials.gov

A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

July 31, 2015

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

PF-00299804

Tablet, single dose of 45 mg via gastrojejunostomy tube (G-Tube) on an empty stomach

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Health Network, Toronto

OTHER

NCT01484847 - A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter